FDAClass IFebruary 9, 2022

ImmunoPass recall

ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60

Why was ImmunoPass recalled?

COVID test kits were offered for sale and distributed to consumers in the United States without marketing approval, clearance, or authorization from FDA.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

all lots

Product
ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60
Recalling firm
Empowered Diagnostics LLC
Quantity
2100 units
Distribution
US Nationwide Distribution
Recall date
February 9, 2022
Classification
Class I
Status
Completed
Agency
FDA (device)
Open FDA enforcement record Latest recalls